What Are B+ Mushrooms? History, Effects & Scientific Background (Educational Guide)

In recent years, interest in psilocybin mushrooms has grown due to expanding scientific research and public discussions around mental health. Among the many varieties discussed in online communities, “B+ mushrooms” are one of the most commonly mentioned strains. However, understanding what B+ mushrooms are requires looking at their biological classification, historical background, psychological effects, and scientific research context.

This guide provides educational information only. Laws regarding psilocybin vary by country, and readers should always review local regulations.

Understanding Psilocybin Mushrooms

B+ mushrooms are a strain of Psilocybe cubensis, a species of mushroom that contains the naturally occurring psychoactive compounds psilocybin and psilocin. When ingested, psilocybin converts into psilocin in the body, which interacts with serotonin receptors in the brain.

Unlike different plant species, strains such as B+, Golden Teacher, or Ecuador are variations within the same species. Scientifically, they are categorized based on their chemical content rather than branding or strain names commonly used online.

Historical Background of Psilocybin Mushrooms

Psilocybin mushrooms have been used for centuries in various cultural and spiritual practices.

Indigenous and Traditional Use

Historical evidence shows that indigenous communities in regions such as Mexico used psilocybin-containing mushrooms in ceremonial and spiritual rituals. These practices were documented by early Spanish chroniclers in the 16th century.

The term “teonanácatl,” often translated as “flesh of the gods,” was used to describe sacred mushrooms in Mesoamerican traditions.

Western Scientific Discovery

Modern Western awareness of psilocybin mushrooms increased in the 1950s. Amateur mycologist R. Gordon Wasson documented ceremonial mushroom use in Mexico, bringing attention to psychedelic fungi in the United States and Europe.

In 1958, Swiss chemist Albert Hofmann successfully isolated and synthesized psilocybin. Hofmann also synthesized LSD earlier in his career, contributing significantly to psychedelic research.

What Makes B+ Mushrooms Distinct?

B+ mushrooms are commonly described in cultivation communities as:

Medium to large in size
Light golden caps
Relatively adaptable to different growing conditions

However, from a scientific perspective, B+ mushrooms are not chemically unique compared to other Psilocybe cubensis strains. Their psilocybin content generally falls within the typical range for the species.

It is important to note that potency can vary based on:

Growing conditions
Harvest timing
Storage methods
Individual mushroom variation

There is no standardized potency scale across strains.

How Psilocybin Affects the Brain

Psilocybin primarily affects serotonin receptors, especially the 5-HT2A receptor subtype. This interaction alters communication between brain regions, which may explain the changes in perception, mood, and cognition.

Researchers using brain imaging techniques have observed:

Reduced activity in the default mode network (DMN)
Increased connectivity between normally separate brain regions
Altered sensory processing

The default mode network is associated with self-referential thinking and ego-based processing. Reduced activity in this network may contribute to experiences described as “ego dissolution.”

Common Psychological Effects

The effects of psilocybin vary widely depending on dosage, environment, and individual psychology.

Perceptual Changes

Users may report:

Enhanced colors and patterns
Altered sense of time
Visual distortions
Heightened sensory awareness

Emotional Effects

Experiences can include:

Euphoria
Deep introspection
Emotional release
Anxiety or fear

Cognitive Changes

Some individuals report:

Creative thinking
Spiritual insights
Shifts in personal perspective

However, difficult experiences — often referred to as “bad trips” — may involve panic, confusion, or paranoia.

Duration of Effects

Psilocybin effects typically begin within 20 to 60 minutes after ingestion and may last 4 to 6 hours. Residual after-effects can persist for several hours beyond the primary experience.

Factors influencing duration include:

Dosage
Body weight
Metabolism
Psychological state
Setting

Scientific Research and Mental Health

In recent years, reputable institutions have studied psilocybin under strict clinical conditions.

Research at Johns Hopkins University and Imperial College London has explored its potential role in treating:

Treatment-resistant depression
Anxiety related to terminal illness
Post-traumatic stress disorder (PTSD)
Substance use disorders

These studies are conducted with:

Careful psychological screening
Controlled dosing
Medical supervision
Structured therapy sessions

It is crucial to distinguish clinical research from unsupervised use.

Legal Status Overview

The legal status of psilocybin varies globally.

In the United States, psilocybin remains federally classified as a Schedule I substance, though some cities and states have decriminalized possession.

In the United Kingdom, it is classified as a Class A drug.

In India, psilocybin falls under narcotics regulations.

The Netherlands allows psilocybin truffles but bans mushrooms.

Because laws change over time, individuals must verify current regulations in their location.

Potential Risks and Considerations

Although psilocybin is not considered physically addictive, it carries potential risks.

Psychological Risks

Panic attacks
Paranoia
Worsening of underlying mental health conditions
Triggering psychosis in vulnerable individuals

Physical Risks

Elevated heart rate
Increased blood pressure
Nausea and vomiting
Impaired coordination

Misidentification Risk

Wild mushroom foraging is extremely dangerous. Toxic species can resemble psilocybin-containing mushrooms and may cause organ failure or death.

Set and Setting: A Research Concept

Modern psychedelic research emphasizes “set and setting”:

Set refers to mindset, expectations, and emotional state.
Setting refers to physical and social environment.

Clinical studies use calm, controlled environments with trained facilitators to reduce psychological risk.

Uncontrolled environments significantly increase the likelihood of distressing experiences.

what are B+ mushrooms?

Public Health Perspective

Organizations such as the World Health Organization emphasize prevention, education, and mental health support in discussions around psychoactive substances.

Education reduces harm more effectively than misinformation or stigma.

Balanced, research-based discussions are critical as global policy conversations evolve.

Frequently Asked Educational Questions

Are B+ mushrooms different from other psilocybin mushrooms?

Scientifically, they belong to the same species (Psilocybe cubensis) as many other commonly referenced strains. Differences are typically related to cultivation traits rather than major chemical differences.

Are they medically approved?

Psilocybin is not broadly approved for medical use in most countries, though research continues under regulatory supervision.

Are they addictive?

Psilocybin is not considered physically addictive, but psychological patterns of misuse can still occur.

Final Thoughts

B+ mushrooms are a strain within the species Psilocybe cubensis, containing the psychoactive compound psilocybin. Their growing visibility in public discussion reflects broader scientific interest in psychedelic research.